MedTrace Logo

Bare Metal Stents and Drug Eluting Stents in Patients Who Underwent Blood Transfusion

NCT03788148 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 28322

Last updated 2018-12-27

No results posted yet for this study

Summary

Retrospective cohort study of Korean National Healthcare Insurance Database. To investigate clinical outcomes of bare metal stents versus drug eluting stents in patients who underwent periprocedural red blood cell transfusion.

Conditions

  • Erythrocyte Transfusion
  • Percutaneous Coronary Intervention
  • Revascularization

Interventions

DEVICE

Stent, red blood cell transfusion

BMS (Bare Metal Stent) and DES (drug-eluting stent) transplants with periprocedural red blood cell transfusion

Sponsors & Collaborators

  • Samsung Medical Center

    lead OTHER

Principal Investigators

  • Jin-Ho Choi, MD, PhD · Samsung Medical Center

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-03
Primary Completion
2018-11-30
Completion
2018-11-30

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03788148 on ClinicalTrials.gov